Oxygen Saturation Clinical Trial
Official title:
Evaluation of Wearable Melanin-Adjusted Blood Oxygen Sensor (MABOS) for Improved Accuracy in Patients of Color
Purpose: Investigate the safe wearability and basic functionality - epidermal melanin concentration and blood oxygen estimation - of our developed device: Melanin-Adjusted Blood Oxygen Sensor (MABOS) Participants: Healthy adults 18-65 years of age Procedures (methods): The investigators plan to enroll 12 healthy adult participants for the study. The investigators aim to enroll 4 participants with skin tones associated with those of African descent (Group A), 4 of East Asian descent (Group B), and 4 of European descent (Group C). Additionally, the investigators aim to ensure half of group is male, and the other half female. For the duration of the study, two wearable devices will be placed on the participant: a Nonin PureSat pulse oximeter on a forefinger, and the novel wearable pulse oximeter - MABOS - on the other forefinger. Prior to testing, an Ocean HR2 XR Spectrometer will be used to assess the absorbance of three wavelengths of light - 410, 660, 940 nm - on each patient's inner wrist. Following this, the two devices will be placed on the patient, set up, and calibrated for 10 minutes. During the calibration period, MABOS will be used to measure the same three wavelengths of light utilized by the Ocean HR2 XR Spectrometer (410, 660, and 940 nm). After the calibration period, all participants will be asked to perform the following procedure 5 times as part of the testing period: a deep inhalation lasting no longer than 10 seconds, followed by a slow exhalation lasting no longer than 30 seconds. Between each trial, a five-minute break will be required. For the entire testing period, all two devices will be continuously acquiring data. After this testing period, all two devices will continue taking measurements until 90 minutes have elapsed. Skin integrity will be examined before spectrometer use, after spectrometer use, after the calibration period, every 30 minutes after the start of the testing period, and after the testing period. During the study, if the participants report any uncomfortable feeling and/or pain or if a change to the skin at the site of device placement occurs, the measurements will be discontinued, and all the devices placed on the participants will be removed. Questionnaires will be provided after the study period and during follow-up visits approximately 48 hours and 96 hours post the device testing visit for a proof-of-concept evaluation of the safe wearability.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Terminated |
NCT05030012 -
Maintaining Optimal HVNI Delivery Using Automatic Titration of Oxygen in Preterm Infants
|
N/A | |
| Recruiting |
NCT06101641 -
Effect of Shellac Nail Polish Application on Pulse Oximetry Measurements in Healthy Individuals
|
N/A | |
| Terminated |
NCT03967587 -
Evaluation of Intravascular Monitoring of Partial PRessure of Oxygen for Neonatal intensiVE Care Patients
|
N/A | |
| Completed |
NCT03683316 -
Work of Breathing and Kangaroo Mother Care
|
||
| Recruiting |
NCT04429906 -
Diagnostic Study of Huami Smart Wearable Device
|
||
| Completed |
NCT05784103 -
Comparison of Tissue Oxygenation Measurement Using Multimodal Devices
|
N/A | |
| Recruiting |
NCT03873298 -
Inhaled NO in IPF and COPD During 6 Minute Walk Test
|
Phase 2 | |
| Completed |
NCT03439202 -
Low Intensity Exercise in Different Normobaric/Hypobaric Normoxic/Hypoxic Conditions.
|
N/A | |
| Not yet recruiting |
NCT06283914 -
Imputation of Arterial Oxygen Partial Pressures Using Pulse Oximetry
|
||
| Recruiting |
NCT05022264 -
Remote Investigation and Assessment of Vital Signs
|
||
| Not yet recruiting |
NCT05886153 -
Verification Protocol for the Cloud DX Vitaliti Continuous Vital Signs Monitor (VERDICT-2)
|
N/A | |
| Completed |
NCT02834845 -
Comparison of Volatile Anesthetics on Cerebral Oxygenation During Controlled Hypotension
|
Phase 4 | |
| Suspended |
NCT04252547 -
Effect of Kangaroo Care on Test Weighing
|
N/A | |
| Completed |
NCT04346498 -
Can Kangarooing Small Babies on the Back of a Mother Keep Them Warm and Stable
|
N/A | |
| Completed |
NCT02127333 -
Role of Oxygen for Vascular Dysfunction
|
N/A | |
| Not yet recruiting |
NCT05451875 -
Comparison of Continuous Non-invasive All Vital Signs Monitoring Devices With Invasive Gold Standard for Children
|
||
| Completed |
NCT05683210 -
Comparison of The Effects of Initial Oral Feeding by Cup and Bottle-Feeding of Preterm Infants
|
N/A | |
| Completed |
NCT02017691 -
Cerebral Oxygenation to Guide Supplemental Oxygen
|
Phase 1/Phase 2 | |
| Completed |
NCT05709262 -
Comparison of Different Walk and Performance Test in Detecting Silent Hypoxia
|